Maternal and Fetal Compatibility in Assisted Reproductive Technology (ART)-Oocyte Donor Influences Live Birth Rate

NCT02718105 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2022-08-11

No results posted yet for this study

Summary

Has the maternal KIR haplotype an impact in pregnancy, miscarriage and live birth rates per embryo transfer in donor oocytes -ART by paternal and oocyte donor HLA-C?

Conditions

Interventions

GENETIC

KIR HLAC determinations

We will take blood samples for KIR HLA-C determinations.

Sponsors & Collaborators

  • IVI Madrid

    lead OTHER

Principal Investigators

  • Juan Antonio Garcia Velasco, PhD · IVI Madrid

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-01-01
Primary Completion
2022-04-01
Completion
2022-08-01

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02718105 on ClinicalTrials.gov